NeuroVive Pharmaceutical AB at its annual general meeting held on May 20, 2020 elected Roger Franklin as new Board member. Roger Franklin will assume office on 9 July 2020.

The company also approved the change the auditor's term of office in the Articles of Association to one year (previously four years). Furthermore, the AGM resolved in accordance with the Board's proposal to change the limits of the Articles of Association for the share capital and the number of shares.